Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChemRar High-Tech Centre is a leading Russian R&D group and investment incubator focused on the development and commercialization of innovative medicines. The center operates as a full-cycle drug discovery and development hub, offering integrated services ranging from medicinal chemistry and high-throughput screening to clinical trials and GMP manufacturing. Its portfolio includes significant commercialized treatments such as Elpida for HIV and Avifavir for COVID-19. ChemRar collaborates extensively with global pharmaceutical companies and academic institutions to advance small molecule therapies across infectious diseases, oncology, and central nervous system disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChemRar High-Tech Centre.